Inhibition of Colon Cancer Recurrence via Exogenous TRAIL Delivery Using Gel-like Coacervate Microdroplets

Colon cancer (CC) belongs to the three major malignancies with a high recurrence rate. Therefore, a novel drug delivery system that can prevent CC recurrence while minimizing side effects is needed. Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) has recently been spotlighted as a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sungjun, Jwa, Yerim, Hong, Jiyeon, Kim, Kyobum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319433/
https://www.ncbi.nlm.nih.gov/pubmed/35877512
http://dx.doi.org/10.3390/gels8070427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319433/
https://www.ncbi.nlm.nih.gov/pubmed/35877512
http://dx.doi.org/10.3390/gels8070427

Ejemplares similares